Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term efficacy and safety of V0034 CR 01B cream in uremic xerosis
2006-002201-31Phase 3Completed
- Sponsor
- Orphagen Therapeutics
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of glycerol in Uraemic Xerosis, sponsored by Orphagen Therapeutics. Primary endpoint: Treatment response of xerosis in Period I. Started Oct 2006; status: completed.
02
Drugs
glycerol
03
Conditions
Uraemic Xerosis
Beyond the preview
Go deeper on 2006-002201-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002201-31.